Clinical Trial Update: Belatacept in Heart Transplantation [Phase 2]

View source ↗

Summary

This clinical trial update shows a Phase 2 study of belatacept for heart transplantation that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Drugs mentioned

• Nulojix (belatacept)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Heart Transplant | Phase 2 | Status: RECRUITING